Weight loss · Columbia, SC
Weight loss and obesity studies in Columbia, SC
6 recruiting studies have a site in Columbia.
6 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Eli Lilly and Company
- Location
- Columbia, SC + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Novo Nordisk A/S
- Location
- Columbia, SC + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice…
Eli Lilly and Company
- Location
- Columbia, SC + 38 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer
University of South Carolina
- Location
- Columbia, SC
- Eligibility basics
- Ages 3–5
- RecruitingHealthy volunteers
Pistachio Snacking and Metabolic Flexibility
University of South Carolina
- Location
- Columbia, SC
- Eligibility basics
- Ages 25–45
- RecruitingHealthy volunteers
Optimal Digital Weight Loss Treatment for Rural Individuals
University of South Carolina
- Location
- Columbia, SC
- Eligibility basics
- Ages 18+
Who these studies look for
Most of these studies set a BMI range and may exclude people taking certain weight-loss medicines or who have had bariatric surgery. Some require a weight-related condition such as type 2 diabetes or high blood pressure.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.